Aktie A3CS7H ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Zylox-Tonbridge Medical Technology Co., Ltd.

Aktien

A3CS7H

CNE100004JD2

2190

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:05 31.05.2024 		% 5 Tage % 1. Jan.
11,04 HKD +3,37 % Intraday Chart für Zylox-Tonbridge Medical Technology Co., Ltd. +6,15 % -11,25 %
09.05. Zylox-Tonbridge Medical Technology Co., Ltd. gibt das Ausscheiden von Hongze Liang als unabhängiger Non-Executive Director bekannt CI
22.03. Zylox-Tonbridge schrumpft Verlust im Geschäftsjahr 2023 um 31% MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Zylox-Tonbridge Medical Technology Co., Ltd. Announces Retirement of Hongze Liang as an Independent Non-Executive Director
Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE
China Grants Marketing Approval to Zylox-Tonbridge's Peripheral Venous Stent System; Shares Fall 7%
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval
Zylox-Tonbridge Medical Technology Co., Ltd. commences an Equity Buyback Plan for 32,461,974 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023.
Zylox-Tonbridge Medical Technology Co., Ltd.'S ZENFlow Tiger? LD PTA Dilatation Catheter Receives ANVISA Marketing Approval
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Zylox-Tonbridge Medical Technology Shrinks 2022 Loss as Revenue Surges 88%
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Nmpa Granted Marketing Approval for Zylox Octoplus Retrievable Inferior Vena Cava Filter of Zylox-Tonbridge Medical Technology Co., Ltd
Zylox-Tonbridge Medical Technology Co., Ltd. Announces Executive Changes
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CS7H Aktie
  4. Nachrichten Zylox-Tonbridge Medical Technology Co., Ltd.
  5. Andere Sprachen